Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Jefferson Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Albany Molecular Research Inc Raises FY 2013 Revenue Guidance-Conference Call

Monday, 9 Sep 2013 06:00am EDT 

Albany Molecular Research Inc announced that it expects to approach $250 million in fiscal 2013. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $252 million for fiscal 2013. 

Company Quote

0.05 +0.33%
24 Dec 2014